We compared the performance of six outcome prediction models -three based on 24-hour data and three based on admission-only data -in a metropolitan university-affiliated teaching hospital with a 10-bed intensive care unit. The Acute Physiology and Chronic Health Evaluation models, version II (APACHE II) and version III-J, and the Simplified Acute Physiology Score version II (SAPS II) are based on 24-hour data and were compared with the Mortality Prediction Model version II and the SAPS version III using international and Australian coefficients (SAPS IIIA).
The outcome prediction model is an epidemiological tool for clinical research, audit and benchmarking. By taking into account pre-existing patient factors such as age or prior health status which affect patient outcome but are outside our control, it is possible to derive a mathematical equation to adjust for these factors 1 . Risk-adjustment is crucial for comparing diverse groups of patients as case mix varies from one hospital to another and illness severity varies between patients, even those with the same diagnosis.
The majority of intensive care units (ICU) across Australia and New Zealand collect the variables for three internationally validated outcome prediction models: 1) the Acute Physiology and Chronic Health Evaluation model version II 2 (APACHE II); 2) the APACHE model version IIIJ 3 (APACHE III) and 3) the Simplified Acute Physiology Score version II (SAPS II) 4 . These data are submitted to the Australian and New Zealand Intensive Care Society Adult Patient Database 5 for the purposes of research and benchmarking. The Australian Health Care Standards supports this endeavour by including this activity as a clinical indicator for intensive care services 6 .
These three models incorporate demographic and clinical variables. Physiological and laboratory data recorded at anytime during the first 24 hours in ICU are screened for highest and lowest values and those with the highest score are used to calculate the predicted risk of (in-hospital) death ( Table 1) . Comparison of the observed outcomes with the predicted outcomes provides a mechanism for grouping and analysing patients for the purposes of research and monitoring and benchmarking of ICU performance 1 .
Several other models that do not depend on 24hour data screening are also available but are not routinely collected in Australia. The Mortality Prediction Model version II 7 (MPM-II) and the latest version of SAPS model 8 (SAPS III) are two examples. The attraction of these models is that they rely on fewer and simpler variables derived from data available at the time of admission ( Table 1) . The SAPS III model provides the option of using Australian-derived coefficients (SAPS IIIA). We sought to compare the performance of these six outcome prediction models in a Level II metropolitan ICU.
METHoDS
This study was undertaken at The Northern Hospital, a 325-bed university-affiliated metropolitan hospital with a 10-bed Level II ICU. All ICU admissions between october 1, 2005 and December 31, 2007 were screened for inclusion. Patients were excluded according to the standard criteria described in the original methodologies for each model. For example, all models exclude readmissions to ICU during the same hospital stay and those transferred to another hospital's ICU.
Data were prospectively extracted from the medical record by the senior registrars and specialists in ICU and then entered into a Microsoft Access 9 database by the ICU ward clerk. Erroneous and missing data were identified by audit filters built into the software and by manual checking of every electronic record. The Glasgow Coma Score was based on the score prior to intubation and/or sedation even if this occurred prior to ICU admission. otherwise the data were collected in accordance with the definitions for each model and the predicted mortality was calculated electronically for each patient using the published coefficients and formulae for each model 10 .
Model performance was assessed by analysing calibration and discrimination parameters 1 . Model calibration describes how closely the predicted outcomes match the observed outcomes. The standardised mortality ratio (SMR) is a simple ratio of the observed and predicted outcomes for the whole population and indicates whether the model over-or under-predicts outcomes. The Hosmer-Lemeshow goodness-of-fit statistics provide a comparison of the observed and predicted outcomes across quantiles of the population 11 . The study population is sorted in order of increasing predicted risk and is then divided into deciles of equal number (C 10 ) or equal risk-interval (H 10 ) and the c 2 value is calculated. A well-calibrated model will have a SMR confidence interval that includes unity and a goodness-of-fit c 2 statistic <18.4 (d.f=10) with a high P value (>0.05), meaning that there is no statistical difference between the observed and the predicted numbers.
Model discrimination describes how well the model distinguishes survivors from non-survivors. We assessed this using the area under the receiver operating characteristic plot (RoC AUC), a method for describing the sensitivity and specificity of the model. An ideal model that correctly predicts the outcome in all patients will have an RoC AUC value of 1.0, whereas a value of 0.5 indicates that the model is no better than chance. We selected a 95% confidence interval for the ROC AUC >0.80 as desirable. Several other parameters for measuring calibration and discrimination are also available 1, 13 .
The duration of the study was determined by the duration of appointment of the two primary researchers (MP and DG) and the aim was to recruit a minimum of 1500 subjects. All data were de-identified and the need for consent waived by the institutional ethics committee.
RESULTS
During the study period there were 1843 ICU admissions. Median age was 66 years (interquartile range=49 to 76) and length of stay in ICU 41 hours Table 2 .
Two hundred and twenty-five records (13%) contained documentation errors that were identified during the data audit phase. The most common were absent data (such as arterial blood gas result or urine output), incorrect Glasgow Coma Score and data entry (transcription) errors. These were all corrected. Arterial blood gases were not available for 187 (11%) admissions and these variables were given the score of zero. There were no other missing data.
Model-specific patient exclusions are summarised in Table 3 and the performance characteristics  of each model in Table 4 . only the SAPS II and SAPS IIIA models fulfilled all predetermined performance criteria. All models, except for APACHE II, had an RoC AUC >0.80. The APACHE III model was the best discriminator (RoC AUC=0.91) but over-predicted mortality risk (SMR=0.66).
DISCUSSIoN
We have demonstrated differences in the performance of ICU outcome prediction models in a single institution. only the SAPS II and SAPS IIIA models fulfilled all of our criteria. The APACHE III model was the best discriminator of survivors and non-survivors but, as with the other models, overpredicted mortality risk. The APACHE II model performed poorly in all parameters and this is not surprising given that this model is now more than 25 years old 2 . Those models based on admission data performed favourably when compared to those based on 24-hour data.
There are a number of recommendations that arise from the results of this pilot study. First, a wider (preferably national) analysis of model performance would appear to be worthwhile. Most ICUs in Australia and New Zealand allocate significant time and resources to collect data for the APACHE II, APACHE III and SAPS II models. We cannot assume that the published ANZICS reports 5 and clinical trials based on these models are valid without adequate assessment of their reliability in Australasian practice. Second, our findings suggest that whichever model is used it needs to be re-calibrated to an Australasian dataset 13 . All the models we tested were originally developed in other countries and it is therefore to be expected that their performance is different in an Australian ICU 14 . This is, in part, demonstrated by the improvement in H 10 and C 10 statistics of the SAPS IIIA model (incorporating Australian coefficients) over the SAPS III model ( Table 4 ). Model recalibration could be undertaken as part of a national assessment process and would greatly assist in improving performance and validity of the preferred model(s).
Third, there appears to be little merit in screening large amounts of complex data over a 24-hour period when simpler and equally robust and internationally validated models based on admission data are now available 8 . Those models that require screening and inclusion of data from the first 24 hours in ICU may be subject to greater risks of data error, therapeutic bias and outcome bias 15 .
Data quality is an important feature of reliable prediction models. Errors are more likely to occur when a larger volume of data needs to be screened, especially when this is performed manually. Lack of trained and experienced data-collectors increases this risk 16 . We found significant documentation errors in 13% of the records in this study.
Therapeutic bias arises when the independent variables incorporated into the model, such as vital signs or laboratory data, are themselves subject to clinical decisions and the quality of care provided. If the monitoring system is itself under the influence of the clinical care that it is attempting to assess, the results of that assessment may be unreliable or misleading.
For example, an ICU that delivers early goaldirected resuscitation, tight glycaemic control, albumin-based resuscitation fluids, aggressive defence of blood pressure, early renal replacement therapy and a restrictive laboratory testing policy, is likely to have lower scores and appear to have 'worse' outcomes (higher SMR) than an ICU that does none of these. This methodological weakness produces a monitoring system that may inadvertently 'reward' poor performance. This may be one reason why the SAPS II model, which relies more heavily on physiological data over 24 hours than the other models (Table 1) , appeared to perform well (Table 4) , but we are unable to confirm this in our study.
outcome bias may arise when the patient is discharged from ICU before the (24-hour) data collection period is complete -the outcome is known before it is 'predicted' and the 'prediction' is based on actual outcome rather than actual risk. Physiological data collected closer to the time of discharge are likely to differ from admission data, especially for patients who die. A model with outcome bias would be expected to 'predict' accurately and perform well.
A significant proportion of our ICU discharges (30%) and deaths (21%) occurred in patients with a LoS <24 hours. A post-hoc analysis (not shown) indicated that the APACHE III and SAPS II models were no more accurate than the admission-based models for predicting outcome in subjects outside the data-collection period.
There are several limitations in our study. The Hosmer-Lemeshow H 10 and C 10 statistics are more sensitive than SMR in assessing calibration and are potentially misleading when analysing large numbers. This is because small numerical differences of limited clinical significance may become statistically significant 11 . This appeared to be the case for the MPM-II and all SAPS models.
All these outcome prediction models were developed in tertiary-referral hospitals in Europe and North America, whereas this study was based on a small cohort from a single institution, in a different country, a number of years after these models were calibrated. Many of our patients were low-risk and did not require intensive organ support therapies (Table 3) . These results may not be applicable to other Australian and New Zealand ICUs.
CoNCLUSIoN
Six outcome prediction models for ICU patients were compared. The SAPS II and SAPS IIIA models were the best overall predictors of ICU outcome in this institution. Although the APACHE III model was the best discriminator it over-predicted the risk of death. The APACHE II model performed poorly in all parameters. All models are likely to improve with recalibration. Models based on admission scores are attractive because they are easier to collect, methodologically sound and their performance appears to be comparable to those based on 24-hour data. The hypotheses generated from this singlecentre study require confirmation in a larger cohort of ICUs.
